Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy

被引：0
|
作者：
Casneuf, Tineke [1 ]
Lysaght, Andrew [2 ]
LeFave, Clare [3 ]
Bald, Jaime [4 ]
Weiss, Brendan [5 ,6 ]
van de Donk, Niels W. C. J. [7 ]
Lokhorst, Henk M. [7 ]
Ahmadi, Tahamtan [4 ]
Sasser, A. Kate [4 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Immuneering Corp, Cambridge, MA USA
[3] LabConnect LLC, Seattle, WA USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Univ Penn, Dept Med, Div Hematol & Oncol, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Daratumumab for the treatment of multiple myeloma
    Touzeau, Cyrille
    Moreau, Philippe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (07) : 887 - 893
  • [32] Daratumumab: Beyond Multiple Myeloma
    Ejaz, Kiran
    Roback, John D.
    Stowell, Sean R.
    Sullivan, Harold C.
    TRANSFUSION MEDICINE REVIEWS, 2021, 35 (03) : 36 - 43
  • [33] The real-world outcomes of multiple myeloma patients treated with daratumumab
    Szabo, Agoston Gyula
    Klausen, Tobias Wirenfeldt
    Levring, Mette Boegh
    Preiss, Birgitte
    Helleberg, Carsten
    Breinholt, Marie Fredslund
    Hermansen, Emil
    Gjerdrum, Lise Mette Rahbek
    Bonlokke, Soren Thorgaard
    Nielsen, Katrine
    Kjeldsen, Eigil
    Iversen, Katrine Fladeland
    Teodorescu, Elena Manuela
    Dokhi, Marveh
    Kurt, Eva
    Strandholdt, Casper
    Andersen, Mette Klarskov
    Vangsted, Annette Juul
    PLOS ONE, 2021, 16 (10):
  • [34] Daratumumab for untreated multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (02): : E80 - E80
  • [35] Proteomic Analysis in Multiple Myeloma Research
    Jana Cumova
    Anna Potacova
    Zbynek Zdrahal
    Roman Hajek
    Molecular Biotechnology, 2011, 47 : 83 - 93
  • [36] Proteomic Analysis in Multiple Myeloma Research
    Cumova, Jana
    Potacova, Anna
    Zdrahal, Zbynek
    Hajek, Roman
    MOLECULAR BIOTECHNOLOGY, 2011, 47 (01) : 83 - 93
  • [37] Proteomic Analysis for Finding Serum Pathogenic Factors and Potential Biomarkers in Multiple Myeloma
    Zhang, Hong-Tao
    Tian, En-Bing
    Chen, Yu-Ling
    Deng, Hai-Teng
    Wang, Qing-Tao
    CHINESE MEDICAL JOURNAL, 2015, 128 (08) : 1108 - 1113
  • [38] Proteomic Analysis for Finding Serum Pathogenic Factors and Potential Biomarkers in Multiple Myeloma
    Zhang Hong-Tao
    Tian En-Bing
    Chen Yu-Ling
    Deng Hai-Teng
    Wang Qing-Tao
    中华医学杂志英文版, 2015, 128 (08) : 1108 - 1113
  • [39] Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
    Li, Xia
    Dosne, Anne-Gaelle
    Ruixo, Carlos Perez
    Ruixo, Juan Jose Perez
    CLINICAL PHARMACOKINETICS, 2023, 62 (05) : 761 - 777
  • [40] Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
    Xia Li
    Anne-Gaëlle Dosne
    Carlos Pérez Ruixo
    Juan Jose Perez Ruixo
    Clinical Pharmacokinetics, 2023, 62 : 761 - 777
12345